GlaxoSmithKline: Hepatitis C, Chronic trials
The registry lists 14 Hepatitis C, Chronic studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 3Phase 2 6Phase 3 4Phase 4 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Dose Ranging of GSK2336805 in Combination TherapyCompletedNCT01648140Phase 2Results posted
- Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected PatientsCompletedNCT01636778Phase 2Results posted
- Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C SubjectsCompletedNCT01439373Phase 2Results posted
- Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver DiseaseCompletedNCT00529568Phase 3Results posted
- Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver DiseaseCompletedNCT00516321Phase 3Results posted
- Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.CompletedNCT02014571Phase 1
- A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy SubjectsCompletedNCT01879462Phase 1
- Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected PatientsWithdrawnNCT00782301Phase 4
- A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3CompletedNCT00656006Phase 2
- Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected AdultsTerminatedNCT00439959Phase 1
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3CompletedNCT00411385Phase 3
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive PatientsCompletedNCT00402428Phase 3
- A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1CompletedNCT00115908Phase 2
- SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis CCompletedNCT00110799Phase 2